Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 206406

Expand all

ENVARSUS XR (TACROLIMUS)
EQ 0.75MG BASE
Marketing Status: Prescription
Active Ingredient: TACROLIMUS
Proprietary Name: ENVARSUS XR
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: EQ 0.75MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N206406
Product Number: 001
Approval Date: Jul 10, 2015
Applicant Holder Full Name: VELOXIS PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information
ENVARSUS XR (TACROLIMUS)
EQ 1MG BASE
Marketing Status: Prescription
Active Ingredient: TACROLIMUS
Proprietary Name: ENVARSUS XR
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: EQ 1MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N206406
Product Number: 002
Approval Date: Jul 10, 2015
Applicant Holder Full Name: VELOXIS PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information
ENVARSUS XR (TACROLIMUS)
EQ 4MG BASE
Marketing Status: Prescription
Active Ingredient: TACROLIMUS
Proprietary Name: ENVARSUS XR
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: EQ 4MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N206406
Product Number: 003
Approval Date: Jul 10, 2015
Applicant Holder Full Name: VELOXIS PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English